150. Cancer Res. 2018 May 10. pii: canres.2676.2017. doi:10.1158/0008-5472.CAN-17-2676. [Epub ahead of print]R-spondin3 is associated with basal-progenitor behavior in normal and tumormammary cells.Tocci JM(1), Felcher CM(1), García Solá ME(2), Goddio MV(1), Zimberlin MN(1),Rubinstein N(3), Srebrow A(3), Coso OA(3), Abba MC(4), Meiss RP(5), Kordon EC(6).Author information: (1)IFIByNE-UBA-CONICET; Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires.(2)FBMC, IFIBYNE-CONICET.(3)FBMC, IFIByNE-UBA-CONICET; Facultad de Ciencias Exactas y Naturales,Universidad de Buenos Aires.(4)CINIBA, Facultad de Medicina, Universidad Nacional de La Plata.(5)Institutio de Estudios Oncologicos, Academia Nacional de Medicinia.(6)Biological Chemistry, School of Exact and Natural Sciences,IFIByNE-UBA-CONICET, Facultad de Ciencias Exactas y Naturales, Universidad deBuenos Aires ekordon@qb.fcen.uba.ar.R-spondin3 (RSPO3) is a member of a family of secreted proteins that enhance Wnt signaling pathways in diverse processes including cancer. However, the role ofRSPO3 in mammary gland and breast cancer development remains unclear. In thisstudy, we show that RSPO3 is expressed in the basal stem cell-enrichedcompartment of normal mouse mammary glands but is absent from committed matureluminal cells in which exogenous RSPO3 impairs lactogenic differentiation. RSPO3 knockdown in basal-like mouse mammary tumor cells reduced canonical Wntsignaling, epithelial-to-mesenchymal transition-like features, migrationcapacity, and tumor formation in vivo. Conversely, RSPO3 overexpression, whichwas associated with some LGR and RUNX factors, highly correlated with thebasal-like subtype among breast cancer patients. Thus we identified RSPO3 as anovel key modulator of breast cancer development and a potential target fortreatment of basal-like breast cancers.Copyright ©2018, American Association for Cancer Research.DOI: 10.1158/0008-5472.CAN-17-2676 PMID: 29748375 